Robert Pape

Robert Pape has a diverse work experience in the field of finance, specifically in Financial Planning & Analysis (FP&A).

Robert is currently working as the Sr. Director of Finance - FP&A at Keros Therapeutics since June 2021. Prior to this, they were associated with Organogenesis, where they held various roles in FP&A. Robert served as the AVP, Financial Planning & Analysis from March 2021 to June 2021, Senior Director of Financial Planning & Analysis from January 2019 to March 2021, and Director of Financial Planning & Analysis from October 2016 to December 2018.

Before joining Organogenesis, Robert worked at NxStage Medical as a Finance Manager from October 2014 to September 2016 and as a Senior Financial Analyst - FP&A from March 2013 to October 2014.

Their earlier experience includes working at Monster Worldwide, where they held multiple roles in Global Financial Planning & Analysis (FP&A). Robert served as an Associate Manager, Finance from July 2011 to March 2013, a Senior Financial Analyst from July 2010 to June 2011, and a Financial Analyst from June 2008 to June 2010.

Robert Pape obtained a Master of Business Administration (MBA) degree from the Questrom School of Business at Boston University, in the period from 2014 to 2017. The field of study during their MBA is unspecified. Prior to this, they completed their undergraduate education at Babson College, where they earned a Bachelor of Science (BS) degree in Business Management. During their time at Babson College, they concentrated on Quantitative Analysis and Computational Finance. No specific start or end years were provided for their undergraduate education.